Recombinant atpB is produced via heterologous expression in E. coli or mammalian cells, depending on the desired form and application. Key characteristics include:
The full-length His-tagged version (UniProt: B6J2D4) is widely used for structural and functional studies, while the partial version (UniProt: B6J957) is tailored for specific applications requiring truncated domains. Both forms are lyophilized or stored in glycerol-containing buffers to prevent degradation.
Recombinant atpB is utilized in:
Although not directly cited in peer-reviewed studies, atpB shares production strategies with other C. burnetii recombinant proteins used in ELISA-based diagnostics . For example:
ELISA Antigen: Potential use in detecting anti-atpB antibodies in Q fever sera, though cross-reactivity with conserved bacterial proteins (e.g., Chlamydia) remains a concern .
Comparative Performance: Recombinant antigens like Com1 (a phase I antigen) show high specificity in sheep, goats, and cattle , suggesting similar potential for atpB.
Limited Functional Data: Most studies focus on C. burnetii effectors (e.g., CvpB, CinF) rather than metabolic enzymes like atpB .
Diagnostic Specificity: Whole-cell antigens risk cross-reactivity; recombinant atpB could improve specificity but requires validation against clinical sera.
Expression Challenges: Mammalian cell-expressed partial atpB may face solubility issues, necessitating optimization .
KEGG: cbu:CBU_1939
STRING: 227377.CBU_1939
ATP synthase subunit a (atpB) is an integral membrane protein component of the F0 sector of the ATP synthase complex in Coxiella burnetii. It plays a crucial role in proton translocation across the bacterial membrane, which drives ATP synthesis through the coupled F1 domain. This protein is encoded by the atpB gene (locus CBU_1939) and consists of 264 amino acids organized into multiple transmembrane helices that form a proton-conducting channel. The protein's function is essential for energy metabolism in C. burnetii, particularly during its obligate intracellular lifestyle within the acidic parasitophorous vacuole .
C. burnetii has evolved to survive within acidic lysosome-derived vacuoles in host cells, making its energy metabolism uniquely adapted to this challenging niche. Recent metabolic studies show that C. burnetii can utilize both glucose and glutamate during infection, with these substrates feeding into pathways that ultimately generate the proton motive force required for ATP synthesis. The ATP synthase complex, including the atpB subunit, appears to function efficiently under acidic conditions, allowing the pathogen to maintain energy homeostasis within the host cell environment. This adaptation is critical for C. burnetii's ability to establish a replication-permissive niche and cause persistent infection .
Successful expression of membrane proteins like atpB requires specialized approaches:
| Expression System | Advantages | Considerations |
|---|---|---|
| E. coli strains specialized for membrane proteins (C41/C43) | Well-established protocols, cost-effective | May require codon optimization for C. burnetii genes |
| Cell-free expression systems (IVTT) | Avoids toxicity issues, rapid production | Higher cost, potentially lower yields |
| Insect cell systems | Better for complex membrane proteins | More complex setup, longer production time |
For atpB specifically, E. coli-based systems with inducible promoters and fusion tags (such as His-tags) have shown success in producing the recombinant protein for analysis and antibody production. The choice of expression vector and host strain should be optimized for membrane protein expression, with special attention to induction conditions to prevent toxicity .
Membrane protein purification requires specialized protocols:
Membrane isolation: Selective fractionation of bacterial membranes containing expressed atpB
Detergent solubilization: Screening of detergents (DDM, LMNG, etc.) for optimal extraction without denaturation
Affinity chromatography: Utilization of introduced tags (typically His-tag) for initial purification
Size-exclusion chromatography: Removal of aggregates and isolation of properly folded protein
Quality assessment: Verification of purity and functional state through electrophoresis and activity assays
The recombinant protein should be maintained in a Tris-based buffer containing 50% glycerol to preserve stability, with storage at -20°C for short-term or -80°C for extended storage. Repeated freeze-thaw cycles should be avoided, and working aliquots can be stored at 4°C for up to one week .
Verification of proper folding is essential for functional studies:
Circular dichroism spectroscopy: Analysis of secondary structure content to confirm proper folding
Limited proteolysis: Assessment of accessible cleavage sites that indicate native conformation
Thermal stability assays: Measurement of protein stability under different buffer conditions
Functional reconstitution: Incorporation into liposomes to assess proton translocation capability
Binding assays: Verification of interactions with known binding partners or inhibitors
These approaches collectively provide evidence that the recombinant protein maintains its native structural features necessary for biological function.
Several complementary approaches can determine topology:
Cysteine scanning mutagenesis: Introduction of cysteine residues at various positions followed by accessibility studies with membrane-impermeable reagents
Protease protection assays: Digestion of accessible regions in intact membrane vesicles versus detergent-solubilized protein
Epitope insertion: Introduction of epitope tags at predicted loops followed by antibody accessibility studies
Cryo-electron microscopy: Structural determination of the assembled ATP synthase complex, potentially revealing atpB orientation
Computational prediction: Use of topology prediction algorithms validated with experimental data
Integration of multiple methods provides the most reliable topological model of membrane insertion and orientation.
Functional analysis requires specialized biophysical techniques:
Liposome reconstitution with pH-sensitive fluorophores: Direct measurement of proton movement across membranes containing atpB
Patch-clamp electrophysiology: Electrical recording of proton conductance through atpB channels
ATP synthesis assays: Measurement of ATP production in reconstituted systems with imposed proton gradients
Site-directed mutagenesis: Systematic alteration of putative proton-conducting residues and assessment of functional consequences
Acidification resistance assays: Testing protein function across pH ranges relevant to the C. burnetii intracellular niche
These methods can establish the mechanistic details of how atpB contributes to ATP synthesis under conditions that mimic the intracellular environment of this pathogen.
Recent metabolic studies have revealed important insights about C. burnetii's energy metabolism:
| Carbon Source | Metabolic Pathway | ATP Synthase Contribution |
|---|---|---|
| Glucose | Glycolysis | Utilizes proton gradient generated by NADH oxidation |
| Glutamate | TCA cycle | Directly couples to electron transport chain activity |
Intracellular C. burnetii appears to utilize both glucose and glutamate during infection, though the metabolic pathway profiles differ between axenically cultivated bacteria and those growing within host cells. The ATP synthase complex plays a crucial role in harvesting energy from these carbon sources, with atpB specifically facilitating the proton translocation that drives ATP synthesis. Disruption of glucose transport affects bacterial metabolism but doesn't completely abolish growth, suggesting metabolic flexibility where amino acids may serve as alternative carbon sources .
The essential nature of ATP synthesis for bacterial survival makes the ATP synthase complex a potential therapeutic target. Research considerations include:
Essentiality assessment: Determining whether atpB is absolutely required for C. burnetii survival
Selective inhibition: Identifying differences between bacterial and human ATP synthases that could be exploited
Inhibitor screening: Development of high-throughput assays to identify compounds that specifically inhibit C. burnetii ATP synthase
Delivery challenges: Designing inhibitors that can penetrate host cells and the C. burnetii-containing vacuole
Resistance mechanisms: Understanding potential compensatory pathways that might emerge upon ATP synthase inhibition
While not specifically explored in current literature, the ATP synthase represents a promising target given its central role in bacterial bioenergetics.
Advanced structural biology and protein interaction studies include:
Co-purification of ATP synthase complexes: Isolation of intact complexes followed by component identification through mass spectrometry
Cross-linking mass spectrometry: Chemical cross-linking of interacting components followed by identification of contact residues
Bacterial two-hybrid systems: Genetic screening for protein-protein interactions adapted for membrane proteins
Single-particle cryo-electron microscopy: Direct visualization of the assembled ATP synthase complex structure
Molecular dynamics simulations: Computational prediction of stable interaction interfaces between components
These complementary approaches can provide a detailed picture of how atpB interacts with other subunits to form a functional ATP synthase complex.
C. burnetii's unique adaptation to acidic intracellular compartments likely involves specialized features of its ATP synthase:
Comparative sequence analysis: Identification of amino acid differences between C. burnetii atpB and homologs from neutralophilic bacteria
pH-dependent activity profiling: Characterization of enzyme activity across pH ranges from 4.0-7.5
Mutation studies: Testing the functional impact of replacing C. burnetii-specific residues with consensus residues from other bacteria
Proton binding kinetics: Measuring how acidic conditions affect proton association/dissociation from key residues
Structural stability analysis: Assessing protein stability under acidic conditions compared to neutral pH
These studies could reveal unique adaptations that allow C. burnetii to maintain ATP synthesis within the acidified parasitophorous vacuole, contributing to our understanding of how this pathogen survives in this challenging niche.
| Challenge | Causes | Methodological Solutions |
|---|---|---|
| Poor expression | Toxicity to host, codon bias, membrane protein | Use tight expression control, codon optimization, membrane protein-specific strains |
| Inclusion body formation | Improper folding, overexpression | Lower induction temperature, use fusion partners, optimize inducer concentration |
| Loss of function during purification | Detergent denaturation | Screen detergent panel, use milder extraction conditions, validate with functional assays |
| Limited stability | Intrinsic membrane protein instability | Add stabilizing agents (glycerol, lipids), maintain at 4°C, avoid freeze-thaw cycles |
| Aggregation during storage | Detergent micelle disruption | Store with 50% glycerol, maintain detergent above CMC, consider newer stabilization technologies |
As recommended in commercial protocols, maintaining the protein in a Tris-based buffer with 50% glycerol and storing working aliquots at 4°C for no more than one week can help preserve functionality for experimental use .
Membrane protein solubility can be enhanced through several strategies:
Detergent screening: Systematic testing of different detergents (mild non-ionic, zwitterionic, etc.) for optimal solubilization
Alternative solubilization platforms: Utilization of styrene-maleic acid copolymer lipid particles (SMALPs), nanodiscs, or amphipols
Buffer optimization: Systematic variation of pH, ionic strength, and additives to enhance solubility
Fusion partners: Addition of solubility-enhancing tags such as MBP or SUMO
Directed evolution approaches: Selection for more soluble variants while maintaining function
Each of these approaches should be validated with functional assays to ensure that improved solubility does not come at the cost of native structure or activity.
Understanding strain variation can provide insights into essential functional domains:
Genomic comparison: Analysis of atpB sequences across reference strains (such as Nine Mile RSA493) and clinical isolates
Polymorphism identification: Mapping of strain-specific variations onto structural models
Selection pressure analysis: Calculation of dN/dS ratios to identify regions under purifying or diversifying selection
Structure-function correlation: Prediction of how observed variations might affect protein function
Experimental validation: Functional comparison of atpB variants from different strains
Evolutionary insights from comparative studies include:
Phylogenetic analysis: Placement of C. burnetii atpB in the context of other alpha-proteobacterial homologs
Identification of unique features: Comparison with ATP synthases from bacteria inhabiting different niches
Adaptation signatures: Detection of amino acid changes associated with adaptation to intracellular lifestyle
Functional domain conservation: Mapping of universally conserved regions essential for ATP synthase function
Horizontal gene transfer assessment: Evaluation of whether atpB shows evidence of exchange with other species
Such comparative approaches can reveal how C. burnetii has adapted its ATP synthase for function in its unique ecological niche as an acidophilic intracellular pathogen.
Replicate design: Minimum of three biological replicates and three technical replicates per condition
Normalization methods: Standardization to protein concentration, unit membrane area, or known reference activities
Statistical testing: Application of appropriate parametric or non-parametric tests based on data distribution
Multiple comparison correction: Use of Bonferroni or false discovery rate adjustments when comparing multiple conditions
Effect size reporting: Inclusion of confidence intervals and magnitudes of differences, not just p-values
Computational resources enhance experimental approaches:
| Analysis Type | Recommended Tools | Application |
|---|---|---|
| Transmembrane topology | TMHMM, TOPCONS, Phobius | Prediction of membrane-spanning regions |
| Homology modeling | Swiss-Model, I-TASSER, AlphaFold | Generation of 3D structural models |
| Molecular dynamics | GROMACS, NAMD | Simulation of protein behavior in membranes |
| Protein-protein interaction | PSICQUIC, STRING | Prediction of interaction partners |
| Conservation analysis | ConSurf, Rate4Site | Identification of functionally important residues |
Integration of these computational approaches with experimental data provides the most comprehensive understanding of C. burnetii atpB structure, function, and interactions.